White seniors more likely to have signs of future eye disease than black seniors

White individuals older than 65 are more likely than black individuals to have characteristics that indicate they will develop more advanced forms of the eye disease age-related macular degeneration (AMD), according to a report in the February issue of Archives of Ophthalmology.

AMD is a leading cause of vision loss in the United States. Early symptoms include the appearance of drusen (large yellow or white spots in the retina), according to background information in the article. Previous studies have shown a potential difference in rates of AMD between black and white individuals.

Susan B. Bressler, M.D., of the Johns Hopkins University School of Medicine, Baltimore, and colleagues analyzed the eyes of 2,520 individuals (average age 73.5 years) of whom 1,854 were white and 666 were black. Photographs of each eye were taken and assessed for several characteristics of AMD, including drusen and abnormal blood vessel growth.

Larger drusen, connected drusen, those covering a larger area and those closer to the center of the eye were more likely to be found in whites. White individuals were also more likely to already have advanced AMD (1.7 percent vs. 1.1 percent of blacks) and geographic atrophy, another form of AMD, (1.8 percent of whites vs. 0.3 percent of blacks).

“Such data strongly suggest that white individuals are more likely to progress to advanced vision-disabling AMD (certainly to geographic atrophy) than black individuals,” the authors conclude. The data also suggest that black individuals may have a mechanism for protection against AMD and other eye abnormalities. “The absence of racial differences in these early lesions in the pericentral (surrounding the center) area suggest that further research is warranted on factors that protect black individuals from lesions in the central zone or promote central lesions in white individuals.”

http://archopht.ama-assn.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Long-term low-dose antiviral treatment reduces eye disease risk from shingles